Mengwei Li
- Topics
- RNA modifications and cancer (6 papers)Cancer-related molecular mechanisms research (5 papers)CAR-T cell therapy research (3 papers)
In The Last Decade
Mengwei Li
19 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Biology 624
- Cancer Research 324
- Oncology 193
- Immunology 165
- Epidemiology 159
Countries citing papers authored by Mengwei Li
This map shows the geographic impact of Mengwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengwei Li more than expected).
Fields of papers citing papers by Mengwei Li
This network shows the impact of papers produced by Mengwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengwei Li. The network helps show where Mengwei Li may publish in the future.
Co-authorship network of co-authors of Mengwei Li
This figure shows the co-authorship network connecting the top 25 collaborators of Mengwei Li. A scholar is included among the top collaborators of Mengwei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengwei Li. Mengwei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | 48 | |
| 5 | 23 | |
| 6 | Trends in insulin resistance: insights into mechanisms and therapeutic strategybreakdown → | 471 |
| 7 | 32 | |
| 8 | 10 | |
| 9 | 135 | |
| 10 | 67 | |
| 11 | 23 | |
| 12 | 57 | |
| 13 | 37 | |
| 14 | 42 | |
| 15 | 56 | |
| 16 | 41 | |
| 17 | 36 | |
| 18 | 116 | |
| 19 | 11 | |
| 20 | 19 |
About Mengwei Li
Mengwei Li is a scholar working on Cancer Research, Applied Psychology and Immunology, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Cancer Research (324 citations), Molecular Biology (624 citations) and Endocrinology, Diabetes and Metabolism (146 citations). Mengwei Li has collaborated with scholars based in China, Australia and Türkiye. Frequent co-authors include Sarra Setrerrahmane, Hanmei Xu, Xiaowei Chi, Ying Wang, Hanmei Xu, Ying Wang, Peiwei Yang, Meng Li, Erhao Zhang and Chenyu Lin. Their work appears in journals such as Journal of the American Chemical Society, Clinical Cancer Research and Expert Systems with Applications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.